NCT00471952View on ClinicalTrials.gov

Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

April 30, 2008

Conditions
Migraine With AuraMigraine Without Aura
Interventions
DRUG

Maxalt 10mg MLT plus Caffeine 75mg

One migraine attack will be treated

DRUG

Maxalt 10mg MLT plus Placebo

One migraine attack will be treated with Maxalt 10mg plus placebo

DRUG

Placebo + Placebo

One migraine attack will be treated with double placebo

Trial Locations (1)

60614

Diamond Headache Clinic, Chicago

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Diamond Headache Clinic

OTHER

NCT00471952 - Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache | Biotech Hunter | Biotech Hunter